Rino-orbital-cerebral Mucormicosys in A Patient Type 1Diabetic: A Case Report

Authors

Hamka Gunawan Marpaung, 1Departemen Ilmu Penyakit Dalam, Fakultas Kedokteran Universitas Indonesia/RS dr. Cipto Mangunkusumo, Jakarta 2Divisi Geriatri, Departemen Ilmu Penyakit Dalam, Fakultas Kedokteran Universitas Indonesia/ RS dr. Cipto Mangunkusumo, Jakarta
Gery Dala Prima Baso, 1Departemen Ilmu Penyakit Dalam, Fakultas Kedokteran Universitas Indonesia/RS dr. Cipto Mangunkusumo, Jakarta 2Divisi Geriatri, Departemen Ilmu Penyakit Dalam, Fakultas Kedokteran Universitas Indonesia/ RS dr. Cipto Mangunkusumo, Jakarta
Aulia Rizka, Divisi Geriatri, Departemen Ilmu Penyakit Dalam, Fakultas Kedokteran Universitas Indonesia/ RS dr. Cipto Mangunkusumo, Jakarta
Erni Juwita Nelwan, Divisi Tropik Infeksi, Departemen Ilmu Penyakit Dalam, Fakultas Kedokteran Universitas Indonesia/ RS dr. Cipto Mangunkusumo, JakartaDivisi Tropik Infeksi,
Retno S. Wardani, Departemen Telinga Hidung Tenggorok, Fakultas Kedokteran Universitas Indonesia/ RS dr. Cipto Mangunkusumo, Jakarta
Retno Wahyuningsih, Departemen Parasitologi Klinik, Fakultas Kedokteran Universitas Indonesia/ RS dr. Cipto Mangunkusumo, Jakarta

Abstract

Mucormycosis is an opportunistic andfrequently fulminating fungal infection causedby members of the family Mucoraceae, orderMucorales and class Zygomycetes which highly invasive and high mortality. Mucormycosis occurs in diabetic patients with poor blood glucose control. We reported a case of rhinocerebral mucormycosis in 20-year-old female patient with type 1 diabetes. The patient was treated for diabetic ketoacidosis and swollen symptoms in the left eye and out secretions from the left nose containing blackish spots. The probable diagnosis of rhinocerebral mucormycosis is made based on the results of direct examination and culture of nasal and palate tissue biopcywhich result suitable for Mucor sp. She was given systemic antifungal therapy with amphotericin B and symptoms of swelling of the left eye and secretions of the left nose with patches of blackness improved.

References

1. Jin-Geun Kim, Hye Jeong Park, Jung Hyun Park, Jiwoong Baek, Hyung Jun Kim, In-Ho Cha, Woong Nam. Importance of immediate surgical intervention and antifungal treatment for rhinocerebral mucormycosis.J Korean Assoc Oral Maxillofac Surg. 2013;39:246- 250. 2. Brad Spellberg ASI. Mucormycosis. In: Kasper DL, Fauci AS, Longo DL, Jameson JL LJ. Harrison’s principles of internal medicine. 2015; 1350–53. 3. Mallis A, Mastronikolis SN, Naxakis SS, Papadas AT. Rhinocerebral mucormycosis : an update. European Review for Medical and Pharmacological Sciences. 2010; 987–992. 4. Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and Clinical Manifestations of Mucormycosis. Clin Infect Dis.2012; 54: 23–34. 5. Skiada A, Pagano L, Groll A, Zimmerli S, Dupont B, Lagrou K et al. Zygomycosis in Europe : analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology ( ECMM ) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect. 2007; 17: 1859–1867. 6. Tacke D, Koehler P, Markiefka B, Cornely OA. Our 2014 approach to mucormycosis. Mycoses. 2014; 1–6. 7. Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL et al. Epidemiology and Outcome of Zygomycosis : A Review of 929 Reported Cases. Clin Infect Dis. 2005; 20892. 8. Cornely OA, Dannaoui E, Groll AH, Lagrou K, Chakrabarti A, Lanternier F et al. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin Microbiol Infect. 2014; 5–26.

Recommended Citation

Marpaung, Hamka Gunawan; Baso, Gery Dala Prima; Rizka, Aulia; Nelwan, Erni Juwita; Wardani, Retno S.; and Wahyuningsih, Retno (2018) "Rino-orbital-cerebral Mucormicosys in A Patient Type 1Diabetic: A Case Report," Jurnal Penyakit Dalam Indonesia: Vol. 5: Iss. 1, Article 8.
DOI: 10.7454/jpdi.v5i1.171
Available at: https://scholarhub.ui.ac.id/jpdi/vol5/iss1/8